CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Purple Innovation, Inc.  (PRPL)
Other Ticker:  
 
 
Price: $6.6600 $0.01 0.150%
Day's High: $6.98 Week Perf: 5.71 %
Day's Low: $ 6.62 30 Day Perf: -2.2 %
Volume (M): 2 52 Wk High: $ 8.83
Volume (M$): $ 13 52 Wk Avg: $6.05
Open: $6.63 52 Wk Low: $4.20



 Market Capitalization (Millions $) 56
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 308
 Net Income (TTM) (Millions $) -17
 Cash Flow (TTM) (Millions $) -15
 Capital Exp. (TTM) (Millions $) 10

Purple Innovation, Inc.


 

Purple Innovation's Segments
 
 
  Company Estimates  
  Revenue Outlook
Purple Innovation does not provide revenue guidance.

Earnings Outlook
Purple Innovation, Inc. does not provide earnings estimates.

 
Geographic Revenue Dispersion

Flowers Foods Inc

Flowers Foods Inc announced first quarter operating income of $90.581 millions

For the first quarter eps growth outpaced revenue increase, where eps advanced by 29.17 % at $0.31 per share, Sales advanced by 4.76 % to $1.26 billions from the same quarter a year ago.

National General Holdings Corp.

Strong Eps Underlines Double Digits Sales Growth

For the first quarter profits soared by 30.91 % to $0.72 per share, followed by Sales increase of 10.33 % to $1.23 billions, compared with the prior year period.

Cumberland Pharmaceuticals Inc.

Break-even, Sharp Topline Growth

In the first quarter Cumberland Pharmaceuticals Inc reached break-even of $0.00 per share compare to $-0.15 a year ago and from $-0.14 per share from the previous quarter.

Sales jumped by 38.6 % to $11.90 millions from $8.59 millions in the same quarter a year ago and sequentially Sales deteriorated by -11.82 % from $13.50 millions.

Hartman Vreit Xxi, Inc.

Company Fail to Break-even Despite Surge in Sales

Hartman Vreit Xxi, Inc announced very strong Sales growth of 464.02 % year on year to $1.58 millions in the first quarter, but increased losses at $-0.12.

Moleculin Biotech, Inc.

Losses Widen but Revenues Unchanged

In the first quarter Moleculin Biotech, Inc increased losses of $-0.14 per share compare to $-0.08 a year ago and increased losses from $-0.10 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AXIM's Profile

Stock Price

AXIM's Financials

Business Description

Fundamentals

Charts & Quotes

AXIM's News

Suppliers

AXIM's Competitors

Customers & Markets

Economic Indicators

AXIM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071